Learn More
Invitrogen™ Human NT-3/NTF3 ELISA Kit
Beschreibung
The Human NeuroTrophic Factor 3 (NT-3) (Hu NTF3) ELISA quantitates Hu NTF3 in human serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Hu NTF3. Principle of the method The Human NTF3 solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
Spezifikation
Spezifikation
| Zugriffsnummer | Gehäuse P20783 |
| Assay-Bereich | 4.12 bis 3000 pg/ml |
| Assay-Empfindlichkeit: | 4 pg/mL |
| Kalibrierbereich | 4 bis 3000 pg/ml |
| Assay | Festphasen-Sandwich-ELISA |
| Konjugat | Biotin |
| Produkttyp | ELISA-Kit |
| Proteinfamilie | Kinase und Inhibitoren |
| Probentyp | Plasma, Serum, Überstand |
| Spezifität | Dieses ELISA-Kit weist keine Kreuzreaktivität mit einem der getesteten Zytokine auf: Humanes Angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, Leptin, MCP-1, MCP-2, MCP-3, MDC, MIP-1 alpha, MIP-1 beta, MIP-1 delta, PARC, PDGF, RANTES, SCF, TARC, TGF-beta, TIMP-1, TIMP-2, TNF-alpha, TNF-beta, TPO, VEGF. |
| Mehr anzeigen |
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.